worries about growth and demand are outweighing the lift from opec s cuts. samsung reports earnings that seem sluggish domestic data and export curbs from japan. shery: happy fourth of july. u.s. equity and bond markets closed on this independence day holiday. let s see how things are shaping up for asian markets. sophie: while our american friends are enjoying their july 4, futures are heading higher ahead of the jobs report due friday, with s&p futures topping 3000 early. ian stocks set for him a mixed end. in australia, we will be gauging reaction to the government devoting income tax relief to the slowing economy. shery: thanks very paul: thanks very much. selina wang. ina: boris johnson told the conservative party campaign meeting that the split from brussels is key to keeping the u.k. together. he said he would prioritize u.k. warnedver the e.u., but that failure to deliver brexit could split the nation apart. tory members would choose brexit even if it meant breaki
seem to be extending the gains, wehough not as advanced as saw yesterday, but we are seeing it much flat. .1%.hanghai composite up the hang seng also gradually higher. is the sentiment turnaround finally when it comes to these chinese markets or do we have to look at some of the rumors of the national team stepping up to the rescue? continue?ctually it seems like the pboc when it comes to the response of these trade frictions is that they are in this for the long haul. not only have they been talking about injecting more into the cash system, which we have been talking about injecting more cash into the financial system they have been talking about potentially another cut in the cards next month. this policy support it self could help to bring a bit of a floor for the market in general. let s tell you how currencies are faring so far. theid see not a lot of reaction when it comes to dollar-yen. no change expected and also, we are seeing why as well. back to 6.8 right now.
Jonathan Barratt, MD, discusses the 52-week data from the phase 1/2 trial of zigakibart, which was presented at the 61st European Renal Association Congress.
/PRNewswire/ Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced that it will hold an in-person and virtual.